Letter: From Classification to Clinical Care: Reflections on Blood Biomarkers in TBI

Abstract

Get full access to this article

View all access options for this article.

References

Bazarian

, Zetterberg

, Buki

, et al. Blood-based biomarkers for improved characterization of Traumatic Brain Injury: Recommendations from the 2024 National Institute for Neurological Disorders and Stroke Traumatic Brain Injury Classi?cation and Nomenclature Initiative Blood-based Biomarkers Working Group. J Neurotrauma, 2025; 42(13–14):1065–1085; doi: 10.1089/neu.2024.0581

Karamian

, Farzaneh

, Khoshnoodi

, et al. Accuracy of GFAP and UCH-L1 in predicting brain abnormalities on CT scans after mild traumatic brain injury: A systematic review and meta-analysis. Eur J Trauma Emerg Surg, 2025; 51(1):68; doi: 10.1007/s00068-024-02697-3

Joint Trauma System. Use of Traumatic Brain Injury Plasma Biomarkers after a Potentially Concussive Event (CPG ID:90). Joint Trauma System Clinical Practice Guideline. U.S. Department of Defense; 2025. Available from: https://jts.health.mil/assets/docs/cpgs/Use_of_TBI_Biomarkers_after_Potentially_Concussive_Event_14_Apr_2025_ID90_v1.1.pdf [Last accessed: September 6, 2025].

Esnault

, Mathais

, D’Aranda

, et al. Fibrin monomers as a predictor of progressive hemorrhagic injury after traumatic brain injury. Neurocrit Care, 2020; 33(1):182–195.

Payen

J-F

, Launey

, Chabanne

, et al.; OXY-TC trial collaborators. Intracranial pressure monitoring with and without brain tissue oxygen in severe traumatic brain injury: A randomized controlled trial (OXY-TC). Lancet Neurol, 2023; 22(11):1005–1014.

Robba

, Graziano

, Picetti

, et al.; CENTER-TBI Participants and Investigators. Biomarker profiles and systemic insults after traumatic brain injury: Insights from the CENTER-TBI study. Intensive Care Med, 2024; 50(3):371–384.